These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 4328575)

  • 1. [Immunogenic value of the diphtheria-tetanus-pertussis trivaccine depending on the quantitative variations of its antigenic components. IV. Immunogenic properties of the pertussis compound].
    Andreescu V; Caffé I; Marion M; Pozsgi N; Stănică E; Stoian C; Kranzdorf H
    Arch Roum Pathol Exp Microbiol; 1970 Sep; 29(3):487-92. PubMed ID: 4328575
    [No Abstract]   [Full Text] [Related]  

  • 2. Experiences with a new combined vaccine against B. parapertussis, Diphtheria, tetanus and B. pertussis employed in a field trial in Prague 10.
    Burianová-Vysoká B; Burian V; Kríz B; Pellar T; Hellerová J; Rádkovský J
    Prog Immunobiol Stand; 1967; 3():335-40. PubMed ID: 4314432
    [No Abstract]   [Full Text] [Related]  

  • 3. Examination of similarities between diphtheria and pertussis and their toxoids provide insight into vaccine-induced protection to Bordetella pertussis.
    Schneerson R; Robbins JB; Taranger J; Lagerård T; Trollfors B
    Dev Biol Stand; 1997; 89():321-6. PubMed ID: 9272366
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunogenic activities of diphtheria-tetanus-pertussis trivaccines in relation with their quantitative composition. I. Experimental study on animals.
    Stanica E; Pozsgi N; Stoian C; Andreescu V; Caffé I; Kranzdorf H; David C
    Prog Immunobiol Stand; 1967; 3():292-3. PubMed ID: 5379948
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of injection site on reactogenicity and immunogenicity of acellular and whole-cell pertussis component diphtheria-tetanus-pertussis vaccines in infants.
    Tapiainen T; Cherry JD; Heininger U
    Vaccine; 2005 Oct; 23(43):5106-12. PubMed ID: 16023771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acellular pertussis vaccines for infants.
    Edwards KM; Decker MD
    N Engl J Med; 1996 Feb; 334(6):391-2. PubMed ID: 8538712
    [No Abstract]   [Full Text] [Related]  

  • 7. [Formation of whooping cough antibodies and immunoglobulins in children during immunization with combined pertussis-diphtheria-tetanus vaccine].
    Sokolovskaia AD; Zakharova MS; Shavrova EN; Shepsoval EIu; Usviat AZ
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Jan; (1):88-91. PubMed ID: 204136
    [No Abstract]   [Full Text] [Related]  

  • 8. New combined alum hydroxide adsorbed diphtheria-tetanus-pertussis-vaccine with parapertussis component. I. Reactogenicity and serological efficacy.
    Burián V; Kubátová E; Kratochvílová M; Buriánová-Vysoká B
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(2):143-7. PubMed ID: 5463707
    [No Abstract]   [Full Text] [Related]  

  • 9. Immunoprophylaxis in pertussis.
    Deb M
    J Commun Dis; 1984 Mar; 16(1):54-60. PubMed ID: 12055788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined reduced-antigen-content diphtheria-tetanus-acellular pertussis and polio vaccine (dTpa-IPV) for booster vaccination of adults.
    Grimprel E; von Sonnenburg F; Sänger R; Abitbol V; Wolter JM; Schuerman LM
    Vaccine; 2005 May; 23(28):3657-67. PubMed ID: 15882526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The immunological basis of the administration of DTP-polio vaccine].
    Cohen H
    Verh K Acad Geneeskd Belg; 2000; 62(4):245-67. PubMed ID: 11004905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antipertussis immune response after 2 and after 3 doses respectively of diphtheria-tetanus-pertussis trivaccine.
    Andreescu V; Caffé I; Marion M; Ivan I; Cuteanu I; Barbu I
    Arch Roum Pathol Exp Microbiol; 1981; 40(3):253-7. PubMed ID: 6277273
    [No Abstract]   [Full Text] [Related]  

  • 13. Cell-mediated immunity and antibody responses to Bordetella pertussis antigens in children with a history of pertussis infection and in recipients of an acellular pertussis vaccine.
    Ausiello CM; Lande R; Urbani F; Di Carlo B; Stefanelli P; Salmaso S; Mastrantonio P; Cassone A
    J Infect Dis; 2000 Jun; 181(6):1989-95. PubMed ID: 10837180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevention of infectious diseases by immunization.
    Brunell PA
    J Allergy Clin Immunol; 1987 Jun; 79(6):848-52. PubMed ID: 2884245
    [No Abstract]   [Full Text] [Related]  

  • 15. Comparative study of the reactogenicity and effectiveness of different combined vaccines against diphtheria, pertussis and tetanus.
    Adam E; Burian V; Kubátová E; Kratochvílovă M; Buriánov'A B; Kyselová M; Demelová M; Hejdová E
    J Hyg Epidemiol Microbiol Immunol; 1970; 14(1):88-101. PubMed ID: 5462049
    [No Abstract]   [Full Text] [Related]  

  • 16. Bacterial split vaccines.
    Schwick HG; Helting TB; Zwisler O
    Prog Clin Biol Res; 1980; 47():143-55. PubMed ID: 6259662
    [No Abstract]   [Full Text] [Related]  

  • 17. Laboratory investigation of immune responses to acellular pertussis vaccines when used for boosting adolescents after primary immunisation with whole cell pertussis vaccines: a comparison with data from clinical study.
    Reynolds E; Walker B; Xing D; Southern J; Asokanathan C; Dagg B; Corbel M; Miller E
    Vaccine; 2006 Apr; 24(16):3248-57. PubMed ID: 16480794
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The value of booster vaccinations against diphtheria, tetanus, pertussis and poliomyelitis.
    Gabutti G
    J Prev Med Hyg; 2008 Mar; 49(1):47-54. PubMed ID: 18792533
    [No Abstract]   [Full Text] [Related]  

  • 19. Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.
    America Academy of Pediatrics Commitee on Infectious Diseases
    Pediatrics; 2006 Mar; 117(3):965-78. PubMed ID: 16382131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant and immunogenic activities of the 73kDa N-terminal alpha-domain of BrkA autotransporter and Cpn60/60kDa chaperonin of Bordetella pertussis.
    Cainelli Gebara VC; Risoléo L; Lopes AP; Ferreira VR; Quintilio W; Lépine F; Silva WD; Raw I
    Vaccine; 2007 Jan; 25(4):621-9. PubMed ID: 17011680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.